Maria Morak

668 total citations
7 papers, 284 citations indexed

About

Maria Morak is a scholar working on Biochemistry, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Maria Morak has authored 7 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Biochemistry, 3 papers in Public Health, Environmental and Occupational Health and 3 papers in Hematology. Recurrent topics in Maria Morak's work include Lipid metabolism and biosynthesis (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Maria Morak is often cited by papers focused on Lipid metabolism and biosynthesis (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Maria Morak collaborates with scholars based in Austria, Germany and United Kingdom. Maria Morak's co-authors include Albin Hermetter, Manfred Kollroser, Gerald N. Rechberger, Hannes Schmidinger, Oskar A. Haas, Florian Kronenberg, Rudolf Zechner, Guenter Haemmerle, R Panzer-Grümayer and Reinhard Grausenburger and has published in prestigious journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Lipid Research.

In The Last Decade

Maria Morak

7 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Morak Austria 7 101 99 86 66 44 7 284
Omama Helal United Kingdom 3 59 0.6× 110 1.1× 14 0.2× 123 1.9× 9 0.2× 4 306
Cara Nelson United States 8 33 0.3× 117 1.2× 27 0.3× 32 0.5× 29 0.7× 32 314
B. Khalfoun France 11 27 0.3× 86 0.9× 33 0.4× 45 0.7× 32 0.7× 20 405
Monique Mathieu France 10 24 0.2× 264 2.7× 34 0.4× 115 1.7× 40 0.9× 13 450
Lynwen A. James United Kingdom 9 17 0.2× 80 0.8× 22 0.3× 67 1.0× 180 4.1× 11 404
A M Faussat France 9 36 0.4× 224 2.3× 75 0.9× 30 0.5× 50 1.1× 10 438
Christopher J. Gafuik Canada 3 18 0.2× 206 2.1× 43 0.5× 29 0.4× 31 0.7× 4 366
Harukuni Akita Japan 10 11 0.1× 171 1.7× 36 0.4× 31 0.5× 35 0.8× 15 380
V. S. Turner United Kingdom 11 13 0.1× 131 1.3× 62 0.7× 99 1.5× 12 0.3× 18 345

Countries citing papers authored by Maria Morak

Since Specialization
Citations

This map shows the geographic impact of Maria Morak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Morak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Morak more than expected).

Fields of papers citing papers by Maria Morak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Morak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Morak. The network helps show where Maria Morak may publish in the future.

Co-authorship network of co-authors of Maria Morak

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Morak. A scholar is included among the top collaborators of Maria Morak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Morak. Maria Morak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Morak, Maria, et al.. (2013). Blocking ETV6/RUNX1-induced MDM2 overexpression by Nutlin-3 reactivates p53 signaling in childhood leukemia. Leukemia. 28(3). 600–608. 30 indexed citations
2.
Inthal, Andrea, Maria Morak, Reinhard Grausenburger, et al.. (2012). CREBBP HAT domain mutations prevail in relapse cases of high hyperdiploid childhood acute lymphoblastic leukemia. Leukemia. 26(8). 1797–1803. 65 indexed citations
3.
Morak, Maria, Hannes Schmidinger, Gerald N. Rechberger, et al.. (2012). Adipose Triglyceride Lipase (ATGL) and Hormone-Sensitive Lipase (HSL) Deficiencies Affect Expression of Lipolytic Activities in Mouse Adipose Tissues. Molecular & Cellular Proteomics. 11(12). 1777–1789. 100 indexed citations
4.
Morak, Maria, Andishe Attarbaschi, Susanna Fischer, et al.. (2012). Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2–harboring clones as main relapse-driving force in childhood ALL. Blood. 120(26). 5134–5142. 42 indexed citations
5.
Morak, Maria, et al.. (2010). Functional Proteomic Analysis of Lipases and Esterases in Cultured Human Adipocytes. Journal of Proteome Research. 9(12). 6334–6344. 14 indexed citations
6.
Morak, Maria, Hannes Schmidinger, Gerald N. Rechberger, et al.. (2009). Differential activity-based gel electrophoresis for comparative analysis of lipolytic and esterolytic activities. Journal of Lipid Research. 50(7). 1281–1292. 19 indexed citations
7.
Wehinger, Andreas, Ivan Tancevski, Wilfried Schgoer, et al.. (2007). Phospholipid Transfer Protein Augments Apoptosis in THP-1–Derived Macrophages Induced by Lipolyzed Hypertriglyceridemic Plasma. Arteriosclerosis Thrombosis and Vascular Biology. 27(4). 908–915. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026